[1]
|
Conrad, N., Verbeke, G., Molenberghs, G., Goetschalckx, L., Callender, T., Cambridge, G., et al. (2022) Autoimmune Diseases and Cardiovascular Risk: A Population-Based Study on 19 Autoimmune Diseases and 12 Cardiovascular Diseases in 22 Million Individuals in the UK. The Lancet, 400, 733-743. https://doi.org/10.1016/S0140-6736(22)01349-6
|
[2]
|
Baena-Diez, J.M., Garcia-Gil, M., Comas-Cufi, M., Ramos, R., Prieto-Alhambra, D., Salvador-Gonzalez, B., et al. (2018) Association between Chronic Immune-Mediated Inflammatory Diseases and Cardiovascular Risk. Heart, 104, 119-126. https://doi.org/10.1136/heartjnl-2017-311279
|
[3]
|
Drosos, G.C., Vedder, D., Houben, E., Boekel, L., Atzeni, F., Badreh, S., et al. (2022) EULAR Recommendations for Cardiovascular Risk Management in Rheumatic and Musculoskeletal Diseases, Including Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Annals of the Rheumatic Diseases, 81, 768-779. https://doi.org/10.1136/annrheumdis-2021-221733
|
[4]
|
Lazou, A., Ikonomidis, I., Bartekova, M., Benedek, T., Makavos, G., Palioura, D., et al. (2020) Chronic Inflammatory Diseases, Myocardial Function and Cardioprotection. British Journal of Pharmacology, 177, 5357-5374. https://doi.org/10.1111/bph.14975
|
[5]
|
Arida, A., Protogerou, A.D., Kitas, G.D. and Sfikakis, P.P. (2018) Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases. International Journal of Molecular Sciences, 19, Article No. 1890. https://doi.org/10.3390/ijms19071890
|
[6]
|
Aviña-Zubieta, J.A., Choi, H.K., Sadatsafavi, M., Etminan, M., Esdaile, J.M. and Lacaille, D. (2008) Risk of Cardiovascular Mortality in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies. Arthritis & Rheumatology, 59, 1690-1697. https://doi.org/10.1002/art.24092
|
[7]
|
Weber, B., Biery, D.W., Singh, A., Divakaran, S., Berman, A.N., Wu, W.Y., et al. (2022) Association of Inflammatory Disease and Long-Term Outcomes among Young Adults with Myocardial Infarction: The Mass General Brigham YOUNG-MI Registry. European Journal of Preventive Cardiology, 29, 352-359. https://doi.org/10.1093/eurjpc/zwaa154
|
[8]
|
Kang, S. and Song, J. (2017) Robust Gene Selection Methods Using Weighting Schemes for Microarray Data Analysis. BMC Bioinformatics, 18, Article No. 389. https://doi.org/10.1186/s12859-017-1810-x
|
[9]
|
Barrett, T., Wilhite, S.E., Ledoux, P., et al. (2013) NCBI GEO: Archive for Functional Genomics Data Sets—Update. Nucleic Acids Research, 41, D991-D995. https://doi.org/10.1093/nar/gks1193
|
[10]
|
Wu, T., Hu, E., Xu, S., et al. (2021) ClusterProfiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data. Innovation (Camb), 2, Article ID: 100141. https://doi.org/10.1016/j.xinn.2021.100141
|
[11]
|
Szklarczyk, D., Gable, A.L., Lyon, D., et al. (2019) STRING V11: Protein-Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets. Nucleic Acids Research, 47, D607-D613. https://doi.org/10.1093/nar/gky1131
|
[12]
|
Otasek, D., Morris, J.H., Bouças, J., Pico, A.R. and Demchak, B. (2019) Cytoscape Automation: Empowering Workflow-Based Network Analysis. Genome Biology, 20, Article No. 185. https://doi.org/10.1186/s13059-019-1758-4
|
[13]
|
Han, H., Cho, J.W., Lee, S., et al. (2018) TRRUST V2: An Expanded Reference Database of Human and Mouse Transcriptional Regulatory Interactions. Nucleic Acids Research, 46, D380-D386. https://doi.org/10.1093/nar/gkx1013
|
[14]
|
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H. and Trajanoski, Z. (2017) Pan-Cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Reports, 18, 248-262. https://doi.org/10.1016/j.celrep.2016.12.019
|
[15]
|
Rafiq, S., Stevens, K., Hurst, A.J., Murray, A., Henley, W., Weedon, M.N., Bandinelli, S., Corsi, A.M., Guralnik, J.M., Ferruci, L., Melzer, D. and Frayling, T.M. (2007) Common Genetic Variation in the Gene Encoding Interleukin-1-Receptor Antagonist (IL-1RA) Is Associated with Altered Circulating IL-1RA Levels. Genes & Immunity, 8, 344-351. https://doi.org/10.1038/sj.gene.6364393
|
[16]
|
Smith, A.J., Keen, L.J., Billingham, M.J., Perry, M.J., Elson, C.J., Kirwan, J.R., Sims, J.E., Doherty, M., Spector, T.D. and Bidwell, J.L. (2004) Extended Haplotypes and Linkage Disequilibrium in the IL1R1-IL1A-IL1B-IL1RN Gene Cluster: Association with Knee Osteoarthritis. Genes & Immunity, 5, 451-460. https://doi.org/10.1038/sj.gene.6364107
|
[17]
|
Ramírez-Pérez, S., De La Cruz-Mosso, U., Hernández-Bello, J., Martínez-Bonilla, G.E., Ramírez-Dueñas, M.G., Pereira-Suárez, A.L., Parra Rojas, I., Martínez-López, E., Macías-Barragán, J. and Muñoz-Valle, J.F. (2017) High Expression of Interleukine-1 Receptor Antagonist in Rheumatoid Arthritis: Association with IL1RN*2/2 Genotype. Autoimmunity, 50, 468-475. https://doi.org/10.1080/08916934.2017.1412431
|
[18]
|
Attur, M., Zhou, H., Samuels, J., Krasnokutsky, S., Yau, M., Scher, J.U., Doherty, M., Wilson, A.G., Bencardino, J., Hochberg, M., Jordan, J.M., Mitchell, B., Kraus, V.B. and Abramson, S.B. (2020) Interleukin 1 Receptor Antagonist (IL1RN) Gene Variants Predict Radiographic Severity of Knee Osteoarthritis and Risk of Incident Disease. Annals of the Rheumatic Diseases, 79, 400-407. https://doi.org/10.1136/annrheumdis-2019-216055
|
[19]
|
Gu, J., Xu, J., Jiao, A., Gao, Z., Zhang, C., Cai, N., Xia, S., Li, J., Wang, Z., Chen, G., Liu, X. and Chen, Y. (2024) The Levels of IL1RN Is a Factor Influencing the Onset of Rheumatoid Arthritis in Non-Alcoholic Fatty Liver Disease. International Immunopharmacology, 128, Article ID: 111528. https://doi.org/10.1016/j.intimp.2024.111528
|
[20]
|
Patti, G., Mega, S., Pasceri, V., Nusca, A., Giorgi, G., Zardi, E.M., D’Ambrosio, A., Dobrina, A. and Di Sciascio, G. (2005) Interleukin-1 Receptor Antagonist Levels Correlate with Extent of Myocardial Loss in Patients with Acute Myocardial Infarction. Clinical Cardiology, 28, 193-196. https://doi.org/10.1002/clc.4960280409
|
[21]
|
Patti, G., D’Ambrosio, A., Mega, S., Giorgi, G., Zardi, E.M., Zardi, D.M., Dicuonzo, G., Dobrina, A. and Di Sciascio, G. (2004) Early Interleukin-1 Receptor Antagonist Elevation in Patients with Acute Myocardial Infarction. Journal of the American College of Cardiology, 43, 35-38. https://doi.org/10.1016/j.jacc.2003.07.032
|
[22]
|
Napetschnig, J. and Wu, H. (2013) Molecular Basis of NF-κB Signaling. Annual Review of Biophysics, 42, 443-468. https://doi.org/10.1146/annurev-biophys-083012-130338
|
[23]
|
Di Donato, J.A., Mercurio, F. and Karin, M. (2012) NF-κB and the Link between Inflammation and Cancer. Immunological Reviews, 246, 379-400. https://doi.org/10.1111/j.1600-065X.2012.01099.x
|
[24]
|
Wilson, C.L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A.M., Gieling, R.G., Chakraborty, J.B., Fox, C., Richardson, C., Callaghan, K., Blair, GE., Fox, N., Lagnado, A., Passos, J.F., Moore, A.J., Smith, G.R., Tiniakos, D.G., Mann, J., Oakley, F. and Mann, D.A. (2015) NFκB1 Is a Suppressor of Neutrophil-Driven Hepatocellular Carcinoma. Nature Communications, 6, Article No. 6818. https://doi.org/10.1038/ncomms9411
|
[25]
|
Cartwright, T., Perkins, N.D. and Wilson, C. (2016) NFκB1: A Suppressor of Inflammation, Ageing and Cancer. FEBS Journal, 283, 1812-1822. https://doi.org/10.1111/febs.13627
|
[26]
|
Margaryan, S., Kriegova, E., Fillerova, R., Smotkova Kraiczova, V. and Manukyan, G. (2020) Hypomethylation of IL1RN and NFκB1 Genes Is Linked to the Dysbalance in IL1β/IL-1Ra Axis in Female Patients with Type 2 Diabetes Mellitus. PLOS ONE, 15, e0233737. https://doi.org/10.1371/journal.pone.0233737
|